Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma

This publication has 37 references indexed in Scilit:

• Glypican-3: From the mutations of Simpson–Golabi–Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma
  Experimental and Molecular Pathology, 2007
• The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
  Laboratory Investigation, 2005
• Roles of heparan-sulphate glycosaminoglycans in cancer
  Nature Reviews Cancer, 2002
• Glypican-3 expression is silenced in human breast cancer
  Oncogene, 2001
• Glypicans: proteoglycans with a surprise
  Journal of Clinical Investigation, 2001
• GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome
  American Journal of Medical Genetics, 2001
• OCI-5/GPC3, a Glypican Encoded by a Gene That Is Mutated in the Simpson-Golabi-Behmel Overgrowth Syndrome, Induces Apoptosis in a Cell Line–specific Manner
  Journal of Cell Biology, 1998
• Expression of the Cell Surface Proteoglycan Glypican-5 Is Developmentally Regulated in Kidney, Limb, and Brain
  Developmental Biology, 1997
• Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome
  Nature Genetics, 1996
• Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine.
  Molecular and Cellular Biology, 1988